2021 AHA科学声明：下肢外周动脉疾病：当代流行病学、管理差距和未来方向

2021-07-28 美国心脏协会 Circulation . 2021 Jul 28

下肢外周动脉疾病（PAD）影响着全球2.3亿成年人，与各种不良临床结果（其他心血管疾病如冠心病和中风以及腿部结果如截肢）的风险增加有关。尽管PAD很普遍且具有临床重要性，但历来没有得到医护人员和患者的

中文标题：

英文标题：

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2021-07-28

简要介绍：

下肢外周动脉疾病（PAD）影响着全球2.3亿成年人，与各种不良临床结果（其他心血管疾病如冠心病和中风以及腿部结果如截肢）的风险增加有关。尽管PAD很普遍且具有临床重要性，但历来没有得到医护人员和患者的重视。这种不重视似乎是多因素造成的（例如，一线诊断测试--踝臂指数在诊所的可用性有限；错误地认为腿部血管疾病不是致命的，诊断PAD不一定会改变临床实践）。在过去的几年里，大量的证据表明，这些看法是不正确的。一些研究一直表明，许多PAD患者没有接受循证治疗。因此，本科学声明为医护人员提供了关于PAD的当代流行病学（如流行率、时间趋势、风险因素和并发症）、诊断的现状（生理测试和成像方式）以及PAD管理的主要差距（如药物、运动疗法和血管再造）的最新情况。该声明还列出了与PAD相关的研究、临床实践和实施方面的主要差距。为了提高对PAD的认识和理解，改善PAD的诊断方法、管理和预后，需要不同方面（如医疗服务提供者、研究人员、专家组织和医疗机构）的协调努力。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=a891f1c002150540, title=2021 AHA科学声明：下肢外周动脉疾病：当代流行病学、管理差距和未来方向, enTitle=Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2021 Jul 28, authorId=0, author=, summary=下肢外周动脉疾病（PAD）影响着全球2.3亿成年人，与各种不良临床结果（其他心血管疾病如冠心病和中风以及腿部结果如截肢）的风险增加有关。尽管PAD很普遍且具有临床重要性，但历来没有得到医护人员和患者的, cover=https://img.medsci.cn/202184/1628091153139_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Wed Jul 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>下肢外周动脉疾病（PAD）影响着全球2.3亿成年人，与各种不良临床结果（其他心血管疾病如冠心病和中风以及腿部结果如截肢）的风险增加有关。尽管PAD很普遍且具有临床重要性，但历来没有得到医护人员和患者的重视。这种不重视似乎是多因素造成的（例如，一线诊断测试--踝臂指数在诊所的可用性有限；错误地认为腿部血管疾病不是致命的，诊断PAD不一定会改变临床实践）。在过去的几年里，大量的证据表明，这些看法是不正确的。一些研究一直表明，许多PAD患者没有接受循证治疗。因此，本科学声明为医护人员提供了关于PAD的当代流行病学（如流行率、时间趋势、风险因素和并发症）、诊断的现状（生理测试和成像方式）以及PAD管理的主要差距（如药物、运动疗法和血管再造）的最新情况。该声明还列出了与PAD相关的研究、临床实践和实施方面的主要差距。为了提高对PAD的认识和理解，改善PAD的诊断方法、管理和预后，需要不同方面（如医疗服务提供者、研究人员、专家组织和医疗机构）的协调努力。</p>, tagList=[TagDto(tagId=6195, tagName=外周动脉疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=45582, guiderKeyword=下肢外周动脉疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16225, appHits=162, showAppHits=0, pcHits=1701, showPcHits=16062, likes=0, shares=8, comments=5, approvalStatus=1, publishedTime=Thu Aug 05 07:44:56 CST 2021, publishedTimeString=2021-07-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 04 23:32:41 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 20:13:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=下肢外周动脉疾病,.pdf)])

下肢外周动脉疾病,.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-09-18 12366zhang

学习

94 0
[GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-08-18 ms1000000675463573

学习

114 0
[GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-08-18 28347049

学习

105 0
[GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-08-11 12393b88m65暂无昵称

学习

105 0
[GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-08-11 12393b88m65暂无昵称

学习了

98 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021 AHA科学声明：下肢外周动脉疾病：当代流行病学、管理差距和未来方向

相关指南

拓展阅读

科室

工具

服务